跳至主要内容
临床试验/NCT01948050
NCT01948050已完成不适用

Pilot Study on Safety and Efficacy of the Non-invasive Transcranial Stimulation (tDCS) to Relieve Neuropathic Pain in Cancer Patients

Beth Israel Medical Center2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
2
主要终点
Pain Intensity

研究概览

简要总结

This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS) to relieve pain in cancer patients who developed neuropathic pain in the affected area after a surgical intervention, radiation therapy, or chemotherapy to treat the disease.

详细描述

This is a pilot study that aims to determine the effect of repetitive tDCS stimulation, performed on five consecutive days at intensity of 2 mA, on pain and somatosensory abnormalities in patients with neuropathic pain that followed surgical, radiation or chemotherapeutic treatment, and to evaluate safety of tDCS in the same model.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pain on the side of the lesion
  • Spontaneous pain with a score for "worst pain in the last 24 hours" >4 on a numeric scale 0-10
  • Must present the following symptoms and signs:
  • Continuous burning, shooting, or lancinating pain.
  • Presence of hyperesthesia
  • Presence of hyperalgesia (to pinprick) and/or allodynia (to light touch)

排除标准

  • Uncontrolled hypertension, uncontrolled diabetes, uncontrolled cardiovascular disease
  • Pain/painful conditions unrelated to the cancer or related treatment
  • Pregnancy
  • History of seizures/epilepsy
  • Any implanted devices (e.g. a cardio stimulator, etc)
  • Active illegal drug/alcohol abuse
  • Unable to follow directions or complete tools in English

结局指标

主要结局

Pain Intensity

时间窗: Assessed at baseline and post tDCS stimulation day 5

Measured on the 11 point numerical paid rating scale with anchor points 0 = no pain and 10 = worst pain possible. The outcome measure "Pain intensity" assessed as a change between baseline and post tDCS stimulation (after stimulation day 5). The calculated change in the range of positive numbers indicates decreased pain intensity post-treatment (eg. baseline 6; post treatment 4; change +2 indicating decrease of pain intensity by 2 points). Similarly, change in range of negative numbers indicates a worsening of pain intensity (eg. baseline 6; post treatment 8; change -2).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Pilot Study of Transcranial Stimulation (tDCS)to... | 临床试验